Guilin Sanjin Pharmaceutical Co.,Ltd.’s Net Profit Rose 22.4% in First Three Quarters of 2023

Guilin Sanjin Pharmaceutical Co.,Ltd. (桂林三金药业股份有限公司) (002275.SZ) reported a net profit of 396.9 million yuan in the first three quarters of 2023, up 22.4% year-on-year.

Meanwhile, the company posted 1.6 billion yuan in revenue, up 13.4% year-on-year.

At the end of the reporting period, it had 3.8 billion yuan in total assets and 854 million yuan in total liabilities, with a liability-to-asset ratio of 22.3%.